With $195 million in facility-specific investment, this project clears AFT's $100 million investment threshold (AFT includes any project meeting $100 million in facility-specific investment OR 100 permanent operating jobs). This project also meets AFT's primary-source verification and physical U.S. manufacturing-footprint requirements.
View full methodology →The pharmaceuticals context.
Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.
At a glance
- Company
- AbbVie
- Industry
- Pharmaceuticals
- Location
- North Chicago, Illinois
- Investment
- $195.0M
- Permanent jobs announced
- 50
- Status
- Under Construction
- Announced
- Aug 12, 2025
- Expected opening
- 2027
- Added to tracker
- Sep 1, 2026
Official references
- AbbVie's September 29, 2025 North Chicago chemical-synthesis API facility groundbreaking announcement https://news.abbvie.com/2025-09-29-AbbVie-Breaks-Ground-on-New-North-Chicago-Active-Pharmaceutical-Ingredient-Manufacturing-Facility
- AbbVie's August 12, 2025 $195 million North Chicago API investment announcement https://news.abbvie.com/2025-08-12-AbbVie-Announces-195-Million-Investment-to-Expand-Active-Pharmaceutical-Ingredient-Manufacturing-in-the-U-S
- Illinois announcement of the first API facility's 50-job commitment https://gov-pritzker-newsroom.prezly.com/governor-pritzker-announces-195-million-investment-from-abbvie-to-expand-manufacturing-footprint-in-illinois